BriaCell and BriaPro Enter Into Asset Purchase Agreement for Exclusive Soluble CD80 License
PHILADELPHIA and VANCOUVER, British Columbia, Feb. 18, 2026 (GLOBE NEWSWIRE) -- BriaCell…
BriaCell Announces Proposed Effective Date of Share Consolidation
August 05, 2025 20:17 ET | Source: BriaCell Therapeutics Corp. PHILADELPHIA and…
